Clinical Research Directory
Browse clinical research sites, groups, and studies.
Exception Cementless Hip Stem
Sponsor: Zimmer Biomet
Summary
This study is a multicenter, retrospective and prospective, non-controlled, non-randomized post market clinical follow-up study. The objectives of this study are to confirm the long-term safety, performance and clinical benefits the Exception Cementless femoral stem (standard and varized) when used in primary total hip arthroplasty.
Official title: Exception Cementless Femoral Stem in Total Hip Arthroplasty. A Multicenter, Retrospective and Prospective, Non-controlled Post Market Clinical Follow-up Study (Implants and Instrumentation)
Key Details
Gender
All
Age Range
18 Years - 100 Years
Study Type
OBSERVATIONAL
Enrollment
332
Start Date
2021-01-01
Completion Date
2025-12
Last Updated
2025-06-18
Healthy Volunteers
Not specified
Conditions
Interventions
Total hip arthoplasty (THA)
Total hip arthroplasty (THA) is a common operative treatment where an arthritic, degenerative or fractured hip joint is replaced with a prosthetic device if conservative options are unable to relieve pain and debilitating symptoms. THA was traditionally performed on patients over 60 years old, but now includes young and active patients, as well as very old ones thanks to the continuous improvement in implant design. Major indications of THA include osteoarthritis, rheumatoid arthritis, avascular necrosis and hip fractures. The THA surgical procedure involves replacing the head of the femur and acetabulum or socket with an artificial prosthesis. This system is composed of a femoral stem that is inserted into the femoral canal, a ball that attaches to the femoral stem, and an acetabular component or shell that replaces the acetabulum.
Locations (6)
Hôpital Princesse Paola
Aye, Belgium
CH Alpes Léman
Contamine-sur-Arve, France
CH Annecy Genevois
Épagny, France
Hopital Renee Sabran
Hyères, France
Clinique Basseres Kacem-Boudhar
Nîmes, France
Hôpitaux Du Léman
Thonon-les-Bains, France